p38-MAPK inhibitor BMS-582949, Purity ≥98%

Cat. No.: X23-10-ZQ890

p38-MAPK inhibitor BMS-582949, Purity ≥98%

Synonym: BMS-582949; 623152-17-0; BMS 582949; BMS582949; UNII-CR743OME9E; CR743OME9E; p38-MAPK inhibitor

  • MDL: MFCD18633248
  • CAS Number: 623152-17-0
  • Compound CID: 10409068
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BMS-582949, soluble in DMSO and insoluble in ethanol and water, targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates. It targets p38 MAPK.
Molecular Weight
406.49
Molecular Formula
C22H26N6O2
Targets
p38 MAPK: 13 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 79 mg/mL (194.35 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BMS-582949 can be utilized in the study of selective p38α MAP kinase inhibition in inflammatory diseases.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.